Alnylam Pharmaceuticals

RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics, which were pioneered by Alnylam, utilize this process to silence the genes that cause or contribute to disease. #ScienceCurious to learn more about #RNAi? Click here: https://bit.ly/3oR8r2l #RNAiTherapeutics #siRNA #GeneSilencing #RNA

For U.S. Healthcare Professionals: Staying up to date on #RareDiseases like primary #hyperoxaluria type 1 (PH1) can help support patient care. Hear from pediatric nephrologist Dr. Stone as she discusses PH1 and an FDA-approved treatment option. https://bit.ly/3ZN7Ulq

HCPs: Conversations about family health history can help your patients understand inherited diseases, like hereditary #ATTR (#hATTR) #amyloidosis. Encourage your patients to discuss health conditions that run in their families to better understand their health. https://bit.ly/3QPohJd #hATTRoadTrip

RNAi therapies are changing lives, and its pioneers say there’s more to come. [Sponsored by Alnylam Pharmaceuticals] https://lnkd.in/g6i6tMVd

Healthcare Professionals: With hereditary #ATTR (#hATTR), toxic misfolded TTR accumulates at multiple sites in the body, including the nerves, heart and digestive system, and ultimately causes symptoms of the disease. Because the deposition of toxic misfolded TTR can lead to irreversible damage, it is important that physicians take a comprehensive and rapid approach to disease management. Learn more about this inherited #RareDisease and an available treatment option for the polyneuropathy of hATTR in a new Alnylam-sponsored article in Healio: https://bit.ly/4f9H9fu #Amyloidosis

U.S. Healthcare Professionals: Navigating a #RareDisease like primary #hyperoxaluria type 1 (PH1) takes a well-coordinated care team. In this article, pediatric nephrologist, Dr. Raymond Quigley, shares how collaboration among specialists can support accurate, timely diagnosis and highlights advancements in disease management that are supporting patient care. Additionally, learn more from Courtney, who discusses her son’s journey with this rare disease. Read the full story: https://bit.ly/49wLl7S

Healthcare Professionals: Hereditary #ATTR (#hATTR) is often misdiagnosed because symptoms can resemble those of other conditions. This can delay critical intervention as toxic misfolded TTR continues to accumulate in the body and cause disease progression. Read more in an Alnylam-sponsored Healio article: https://bit.ly/4f9H9fu #Amyloidois

HCPs: Conversations about family health history can help your patients understand inherited diseases, like hereditary #ATTR (#hATTR) #amyloidosis. Encourage your patients to discuss health conditions that run in their families to better understand their health. https://bit.ly/3QPohJd #hATTRoadTrip

Healthcare Professionals: People living with hereditary #ATTR (#hATTR) often experience significant and irreversible disease progression before an accurate diagnosis is made. In a new Alnylam-sponsored Healio article, Johanna Contreras, MD, MSc and Said Beydoun, MD, FAAN discuss the urgency to diagnose and manage this inherited #RareDisease. Learn more: https://bit.ly/4f9H9fu #Amyloidois

Doctors appointments, tests, pharmacy visits, medication routines - the sounds of these things make living with disease noisy. But when disease is silenced, these things become less prevalent and the everyday joys of life can be amplified. We've pioneered #RNAi therapeutics to do just that - #SilenceDisease to #AmplifyLife.